BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25564186)

  • 1. New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants.
    Lyle CA; Sidonio RF; Goldenberg NA
    Curr Opin Pediatr; 2015 Feb; 27(1):18-25. PubMed ID: 25564186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
    Ageno W; Spyropoulos AC; Turpie AG
    Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
    Wharin C; Tagalakis V
    Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the Target-Specific Oral Anticoagulants in Development for the Treatment and Prevention of Venous Thromboembolism.
    Devabhakthuni S; Yoon CH; Pincus KJ
    J Pharm Pract; 2016 Aug; 29(4):392-405. PubMed ID: 25634013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
    Ay C; Pabinger I
    Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboprophylaxis in a pediatric hospital.
    Sharma M; Carpenter SL
    Curr Probl Pediatr Adolesc Health Care; 2013 Aug; 43(7):178-83. PubMed ID: 23890025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma.
    Hanson SJ; Punzalan RC; Arca MJ; Simpson P; Christensen MA; Hanson SK; Yan K; Braun K; Havens PL
    J Trauma Acute Care Surg; 2012 May; 72(5):1292-7. PubMed ID: 22673257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
    Tarango C; Schulman S; Betensky M; Goldenberg NA
    Expert Rev Hematol; 2018 Jan; 11(1):37-44. PubMed ID: 29183221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative.
    Raffini L; Trimarchi T; Beliveau J; Davis D
    Pediatrics; 2011 May; 127(5):e1326-32. PubMed ID: 21464186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation after venous thromboembolism. Deciding on the optimal duration.
    Eichinger S
    Hamostaseologie; 2013 Aug; 33(3):211-7. PubMed ID: 23719863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in pediatric venous thromboembolism.
    Gillespie MA; Lyle CA; Goldenberg NA
    Curr Opin Hematol; 2015 Sep; 22(5):413-9. PubMed ID: 26203734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the new emerging oral anticoagulants for venous thromboembolism prophylaxis.
    Welle MK
    Orthop Nurs; 2012; 31(5):265-78; quiz 279-80. PubMed ID: 22968380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline on the investigation, management and prevention of venous thrombosis in children.
    Chalmers E; Ganesen V; Liesner R; Maroo S; Nokes T; Saunders D; Williams M;
    Br J Haematol; 2011 Jul; 154(2):196-207. PubMed ID: 21595646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients.
    Bell AD; Hockenberry M; Landier W; Ewing N
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):455-8. PubMed ID: 26181417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
    Barsam SJ; Patel R; Arya R
    Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
    Merli G; Spyropoulos AC; Caprini JA
    Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.